OptimizeRx Corp.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a OPRX research report →
About the company
OptimizeRx Corp. is digital health company, engaged in the provision of digital health messaging via electronic health records, which serve as a direct channel for pharmaceutical companies to communicate with healthcare providers. It offers electronic health record (EHR) workflow solutions which include financial messaging, patient education, and brand messaging and brand support.
- CEO
- Stephen L. Silvestro
- IPO
- 2007
- Employees
- 136
- HQ
- Waltham, MA, US
Price Chart
- Market Cap
- $116.16M
- P/E
- 16.89
- P/S
- 1.08
- P/B
- 0.90
- EV/EBITDA
- 6.33
- Div Yield
- 0.00%
- Gross Margin
- 69.05%
- Op Margin
- 13.57%
- Net Margin
- 6.37%
- ROE
- 5.47%
- ROIC
- 6.53%
- Revenue
- $109.43M · 18.78%
- Net Income
- $5.13M · 125.52%
- EPS
- $0.28 · 125.45%
- Op Income
- $12.06M
- FCF YoY
- 290.56%
- 52W High
- $22.25
- 52W Low
- $4.54
- 50D MA
- $5.54
- 200D MA
- $10.94
- Beta
- 1.08
- Avg Volume
- 485.69K
Get TickerSpark's AI analysis on OPRX
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jun 9, 26 | KLEMA CATHY | other | 34,517 |
| Jun 9, 26 | Lang James Paul | other | 34,517 |
| Jun 9, 26 | Presti Mariyamma Varghese | other | 17,258 |
| Jun 9, 26 | Spangler Patrick D | other | 34,517 |
| Jun 9, 26 | Vos Ellen O'Connor | other | 34,517 |
| Jun 9, 26 | WASSON GREGORY D | other | 34,517 |
| May 1, 26 | Presti Mariyamma Varghese | other | 13,060 |
| May 15, 26 | Greco Theresa | other | 914 |
| May 15, 26 | Greco Theresa | other | 879 |
| May 15, 26 | Silvestro Stephen L | other | 5,219 |
Our OPRX coverage
Recent articles, reports, and earnings notes.
No research on OPRX yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate OPRX report →Similar companies
Peers in the same neighborhood.